Log in to save to my catalogue

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of lif...

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of lif...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b5226a410544e0dae621b491edeaa0b

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up

About this item

Full title

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2012-07, Vol.9 (1), p.167-167, Article 167

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Expression of inflammatory cytokines in cerebrospinal fluid (CSF) has led to the hypothesis of intrathecal chronic inflammation to explain the denervation observed in post-polio syndrome (PPS). It has been shown that therapy with intravenous immunoglobulin (IVIG) improves physical performance and dampens down the inflammatory process at 6 months in...

Alternative Titles

Full title

Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0b5226a410544e0dae621b491edeaa0b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0b5226a410544e0dae621b491edeaa0b

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/1742-2094-9-167

How to access this item